|
Showing the most relevant articles for your search:NYSE:ACL | 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 | | 2021/01/07 | 15 : 01 | Business Wire | Alcon Announces Launch of AcrySof IQ Vivity, the First & Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the... | NYSE:ACL | Alcon, Inc. |
| 2021/01/07 | 15 : 01 | Business Wire | Alcon Announces Launch of AcrySof IQ Vivity, the First & Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the... | NYSE:ACL | Alcon, Inc. |
| 2015/12/02 | 07 : 21 | Business Wire | Associated Capital Group, Inc. to Ring New York Stock Exchange Opening Bell | NYSE:ACL | Alcon, Inc. |
| 2012/12/03 | 21 : 00 | PR Newswire (US) | Magenta Medical, Developer of Novel Heart Failure Therapy, Secures $4 Million in Seed Round from Pitango Venture Capital | NYSE:ACL | Alcon, Inc. |
| 2011/09/20 | 23 : 45 | Zacks | Wright Medical Gets a New CEO - Analyst Blog | NYSE:ACL | Alcon, Inc. |
| 2011/04/12 | 04 : 10 | Edgar (US Regulatory) | Amended Statement of Ownership: Private Transaction (SC 13E3/A) | NYSE:ACL | Alcon, Inc. |
| 2011/04/12 | 02 : 29 | Edgar (US Regulatory) | (25-NSE) | NYSE:ACL | Alcon, Inc. |
| 2011/04/11 | 22 : 30 | PR Newswire (US) | The Zacks Analyst Blog Highlights: Alcon, Novartis AG, Lazard, Celgene and Elan | NYSE:ACL | Alcon, Inc. |
| 2011/04/11 | 21 : 15 | Zacks | NVS Amends sNDA; Completes Merger - Analyst Blog | NYSE:ACL | Alcon, Inc. |
| 2011/04/08 | 23 : 49 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:ACL | Alcon, Inc. |
| 2011/04/08 | 23 : 47 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:ACL | Alcon, Inc. |
| 2011/04/08 | 23 : 45 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:ACL | Alcon, Inc. |
| 2011/04/08 | 23 : 42 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:ACL | Alcon, Inc. |
| 2011/04/08 | 23 : 39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:ACL | Alcon, Inc. |
| 2011/04/08 | 22 : 00 | Dow Jones News | Watson Discloses Challenge To Generic Eye Drug Application | NYSE:ACL | Alcon, Inc. |
| 2011/04/08 | 20 : 15 | Zacks | Alcon Shareholders Approve Merger - Analyst Blog | NYSE:ACL | Alcon, Inc. |
| 2011/04/08 | 05 : 28 | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NYSE:ACL | Alcon, Inc. |
| 2011/04/08 | 05 : 15 | Business Wire | Alcon Shareholders Approve Merger with Novartis | NYSE:ACL | Alcon, Inc. |
| 2011/03/26 | 06 : 22 | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NYSE:ACL | Alcon, Inc. |
| 2011/03/25 | 19 : 01 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NYSE:ACL | Alcon, Inc. |
| 2011/03/19 | 07 : 04 | Business Wire | Alcon Files Form 20-F with U.S. Securities and Exchange Commission | NYSE:ACL | Alcon, Inc. |
| 2011/03/15 | 19 : 02 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NYSE:ACL | Alcon, Inc. |
| 2011/03/01 | 20 : 07 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NYSE:ACL | Alcon, Inc. |
| 2011/03/01 | 20 : 07 | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NYSE:ACL | Alcon, Inc. |
| 2011/03/01 | 01 : 34 | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NYSE:ACL | Alcon, Inc. |
| 2011/02/28 | 15 : 01 | Business Wire | Alcon Announces Date of Annual General Meeting | NYSE:ACL | Alcon, Inc. |
| 2011/02/25 | 03 : 22 | Edgar (US Regulatory) | Amended Statement of Ownership: Private Transaction (SC 13E3/A) | NYSE:ACL | Alcon, Inc. |
| 2011/02/24 | 23 : 30 | PR Newswire (US) | Zacks Releases Four Powerful 'Buy' Stocks: NVIDIA, Alcon, Rosetta Resources and Corn Products International | NYSE:ACL | Alcon, Inc. |
| 2011/02/17 | 20 : 06 | Edgar (US Regulatory) | Amended Statement of Ownership: Private Transaction (SC 13E3/A) | NYSE:ACL | Alcon, Inc. |
| 2011/02/16 | 02 : 04 | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NYSE:ACL | Alcon, Inc. |
|
Showing the most relevant articles for your search:NYSE:ACL |
|